Arnon Aharon
Head of Clinical development
Clinical development
Chemomab
Israel
Biography
Dr. Aharon joined ChemomAb in 2016 as head of clinical development. Prior to joining ChemomAb, Dr. Aharon served as Chief Medical Officer at BioLineRx Ltd. (NASDAQ/TASE: BLRX). In BioLineRx he was responsible for the development of the company’s pipeline focused on oncology and immunology. Dr. Aharon is a founder and partner in R&D Integrative Solutions, a firm that provides consulting services to the biotechnology industry and academic centers. Prior to the establishment of R&D Integrative Solutions Dr. Aharon served in several management positions including Clinical Director, Medical Director, VP of Development at several biotechnology companies, such as Pharmos Ltd. (NASDAQ/TASE: PARX); Thrombotech Ltd.; and LycoRed Ltd. Dr. Aharon holds an M.D degree from the University of Tel Aviv, Israel and has experience in internal medicine. Dr. Aharon joined ChemomAb in 2016 as head of clinical development. Prior to joining ChemomAb, Dr. Aharon served as Chief Medical Officer at BioLineRx Ltd. (NASDAQ/TASE: BLRX). In BioLineRx he was responsible for the development of the company’s pipeline focused on oncology and immunology. Dr. Aharon is a founder and partner in R&D Integrative Solutions, a firm that provides consulting services to the biotechnology industry and academic centers. Prior to the establishment of R&D Integrative Solutions Dr. Aharon served in several management positions including Clinical Director, Medical Director, VP of Development at several biotechnology companies, such as Pharmos Ltd. (NASDAQ/TASE: PARX); Thrombotech Ltd.; and LycoRed Ltd. Dr. Aharon holds an M.D degree from the University of Tel Aviv, Israel and has experience in internal medicine.
Research Interest
Clinical development
